Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.
about
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.Chronic myeloid leukemia: First-line drug of choice.T315I clone selection in a Ph+ all patient under low-dose ponatinib maintenance.Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinibNovel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesCombined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia.Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation
P2860
Q38389475-7DD477DD-9877-4658-9835-C3EB1F8A12E2Q38697314-B9E4CDA4-A7D8-498C-B17D-BDB43E382324Q41196527-32A6F608-FFDA-4B02-B422-7F031FC40694Q41304682-69133430-DA3B-4C73-B438-ABE299FDC3E0Q41651460-6BA53FB8-9058-40CF-BE62-C86625C3E3DCQ47117016-8843DB76-32BD-4A2F-BFE4-D4A4ED65488BQ47150923-22322D70-663A-43F9-9656-E0C7DFEB39B6Q47269765-F9391E4E-650C-45B5-B8B9-35D85777B6A0Q47705734-D5EDFEBE-CE34-40F5-85B1-B00775EF1FE3Q48186139-49574F02-08F4-45F8-B7EA-C96209F6AF0AQ58761411-FE3526F0-F142-4F77-A478-3242B711D9B4
P2860
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@ast
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@en
type
label
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@ast
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@en
prefLabel
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@ast
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@en
P2093
P2860
P50
P1476
Ponatinib as first-line treatm ...... hronic phase: a phase 2 study.
@en
P2093
Evguenia Gachimova
Graciela Nogueras Gonzalez
Naval Daver
Naveen Pemmaraju
Preetesh Jain
Steven Kornblau
P2860
P304
P356
10.1016/S2352-3026(15)00127-1
P50
P577
2015-09-01T00:00:00Z